Mice treated with GrB/VEGF121 at 27 mg/mg had very limited tumor growth, whereas those treated with a lower dose of GrB/VEGF121 (11 mg/kg) showed tumor growth of about threefold over 30 days. The gene discussed is GZMB; the disease is neoplasm.